15 insiders reported 86 Form 4 transactions for SpringWorks Therapeutics, Inc. (SWTX) over the past 18 months (most recent 2025-07-02). Recent activity: Islam Saqib (Chief Executive Officer) Sell 954,869 shares, LYNCH DANIEL (Director) Sell 93,004 shares, Nofi Michael (Chief Accounting Officer) Sell 30,623 shares, Edris Badreddin (Chief Operating Officer) Sell 169,712 shares, Hambleton Julie (Director) Sell 14,155 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-02 | Islam Saqib | Chief Executive Officer | Sell | 954,869 | $0 |
| 2025-07-02 | LYNCH DANIEL | Director | Sell | 93,004 | $0 |
| 2025-07-02 | Nofi Michael | Chief Accounting Officer | Sell | 30,623 | $0 |
| 2025-07-02 | Edris Badreddin | Chief Operating Officer | Sell | 169,712 | $0 |
| 2025-07-02 | Hambleton Julie | Director | Sell | 14,155 | $0 |
| 2025-07-02 | ALBAN CARLOS | Director | Sell | 28,861 | $0 |
| 2025-07-02 | Weinstein Herschel S | General Counsel & Secretary | Sell | 55,239 | $0 |
| 2025-07-02 | Ashar Bhavesh | Chief Commercial Officer | Sell | 62,053 | $0 |
| 2025-07-02 | Lewis-Hall Freda C | Director | Sell | 24,727 | $0 |
| 2025-07-02 | Perier Francis I Jr | Chief Financial Officer | Sell | 60,889 | $0 |
| 2025-07-02 | Pichl Daniel | Chief People Officer | Sell | 50,762 | $0 |
| 2025-07-02 | Fuhrman Alan | Director | Sell | 24,727 | $0 |
| 2025-07-02 | Lin Tai-An | Chief Scientific Officer | Sell | 33,039 | $0 |
| 2025-07-02 | Cassidy James | Chief Medical Officer | Sell | 81,731 | $0 |
| 2025-07-02 | MACKAY MARTIN | Director | Sell | 20,023 | $0 |
| 2025-05-15 | Fuhrman Alan | Director | Buy | 10,060 | $0 |
| 2025-05-15 | LYNCH DANIEL | Director | Buy | 10,060 | $0 |
| 2025-05-15 | ALBAN CARLOS | Director | Buy | 10,060 | $0 |
| 2025-05-15 | MACKAY MARTIN | Director | Buy | 10,060 | $0 |
| 2025-05-15 | Hambleton Julie | Director | Buy | 10,060 | $0 |
| 2025-05-15 | Lewis-Hall Freda C | Director | Buy | 10,060 | $0 |
| 2025-03-05 | Edris Badreddin | Chief Operating Officer | Sell | 400 | $22,480 |
| 2025-03-05 | Edris Badreddin | Chief Operating Officer | Sell | 3,924 | $208,443 |
| 2025-03-05 | Edris Badreddin | Chief Operating Officer | Sell | 12,078 | $655,352 |
| 2025-03-05 | Edris Badreddin | Chief Operating Officer | Sell | 3,598 | $198,322 |
Source: SEC Form 4 filings · as of 2025-07-02
